Liver fibrosis is scarring of the liver. It has many causes, including alcohol-induced damage, infections, and diseases that harm the liver. Inflammation and injury of the liver can lead to scarring, ...
ATTO01310 targets IL31, while ATTO-002 hits both IL31 and IL13. The first clinical trial, of ATTO-002, is due to get underway next year. The financing was led by Goldman Sachs Alternatives ...